This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
PRIMARY OBJECTIVE: I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases. OUTLINE: Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
Study Type
OBSERVATIONAL
Enrollment
70
Medical records reviewed
Correlative studies
M D Anderson Cancer Center
Houston, Texas, United States
RECRUITINGClinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.